01 1Jubilant Pharmova Limited
01 1zoledronic acid
01 1India
NDC Package Code : 65372-1117
Start Marketing Date : 2006-12-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A zoledronic acid anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of zoledronic acid anhydrous, including repackagers and relabelers. The FDA regulates zoledronic acid anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. zoledronic acid anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A zoledronic acid anhydrous supplier is an individual or a company that provides zoledronic acid anhydrous active pharmaceutical ingredient (API) or zoledronic acid anhydrous finished formulations upon request. The zoledronic acid anhydrous suppliers may include zoledronic acid anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of zoledronic acid anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing zoledronic acid anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for zoledronic acid anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture zoledronic acid anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain zoledronic acid anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a zoledronic acid anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of zoledronic acid anhydrous suppliers with NDC on PharmaCompass.
We have 1 companies offering zoledronic acid anhydrous
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
